Reality on the ground:
- 6 quarters of cash remaining.
- Cash outflow accelerated over the past two quarters: from -3 to -5 and now -6. The rest is cheap talk
- Can you find quarterly receipts in this report? I wonder why: Q1: 3.1 => Q2: 2.9 => Q3: 2.6. Here we go with growth. What a spectacular FFFF.
- Operational numbers minimal: clinical data and the ridiculous accumulative tests (slide #15) are presented instead. The arrow in slide #15 insults the reader: you expected the accumulative number of tests to decline? I can smell duplicity, weakness, and hiding from where I am sitting (which is quite distant).
For me, it's time to wear the big boys' pants, sell, and cut losses.
Reality on the ground:- 6 quarters of cash remaining. - Cash...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.004(6.15%) |
Mkt cap ! $139.5M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.9¢ | 6.5¢ | $138.9K | 2.117M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 84169 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
0.004 ( 4.62 %) |
||||
| Open | High | Low | Volume | ||
| 6.6¢ | 6.8¢ | 6.5¢ | 402373 | ||
| Last updated 15.56pm 14/06/2024 ? | |||||
| IPD (ASX) Chart |